260 related articles for article (PubMed ID: 29058791)
41. High programmed death 1 expression on T cells in aplastic anemia.
Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
[TBL] [Abstract][Full Text] [Related]
42. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
43. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
Front Immunol; 2019; 10():2430. PubMed ID: 31681314
[No Abstract] [Full Text] [Related]
44. Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient.
Zhong R; Zhang Y; Chen D; Cao S; Han B; Zhong H
Cancer Immunol Immunother; 2021 Aug; 70(8):2261-2274. PubMed ID: 33506299
[TBL] [Abstract][Full Text] [Related]
45. Granulocytic myeloid-derived suppressor cells inhibit T follicular helper cells during experimental Schistosoma japonicum infection.
Zhang Y; Wu Y; Liu H; Gong W; Hu Y; Shen Y; Cao J
Parasit Vectors; 2021 Sep; 14(1):497. PubMed ID: 34565440
[TBL] [Abstract][Full Text] [Related]
46. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
[TBL] [Abstract][Full Text] [Related]
47. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
[TBL] [Abstract][Full Text] [Related]
48. Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Zerdes I; Sifakis EG; Matikas A; Chrétien S; Tobin NP; Hartman J; Rassidakis GZ; Bergh J; Foukakis T
Mol Oncol; 2020 May; 14(5):951-963. PubMed ID: 32115850
[TBL] [Abstract][Full Text] [Related]
49. Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
Dong L; Lv H; Li W; Song Z; Li L; Zhou S; Qiu L; Qian Z; Liu X; Feng L; Meng B; Fu K; Wang X; Pan-Hammarström Q; Wang P; Wang X; Zhang H
Oncotarget; 2016 May; 7(22):33350-62. PubMed ID: 27147575
[TBL] [Abstract][Full Text] [Related]
50. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
Wang Z; Tan F
Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
[TBL] [Abstract][Full Text] [Related]
51. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
[TBL] [Abstract][Full Text] [Related]
52. PD-1 Deficiency Promotes Macrophage Activation and T-Helper Cell Type 1/T-Helper Cell Type 17 Response in
Zhang C; Rong HM; Li T; Zhai K; Tong ZH
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):767-782. PubMed ID: 32048861
[No Abstract] [Full Text] [Related]
53. [Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].
Li M; Xu S; Fan H; Zhang H; Li Y; Li Y; Liu M; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):847-853. PubMed ID: 27978870
[TBL] [Abstract][Full Text] [Related]
54. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface.
Meggyes M; Miko E; Szigeti B; Farkas N; Szereday L
BMC Pregnancy Childbirth; 2019 Feb; 19(1):74. PubMed ID: 30782114
[TBL] [Abstract][Full Text] [Related]
55. Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.
Vilain RE; Menzies AM; Wilmott JS; Kakavand H; Madore J; Guminski A; Liniker E; Kong BY; Cooper AJ; Howle JR; Saw RPM; Jakrot V; Lo S; Thompson JF; Carlino MS; Kefford RF; Long GV; Scolyer RA
Clin Cancer Res; 2017 Sep; 23(17):5024-5033. PubMed ID: 28512174
[No Abstract] [Full Text] [Related]
56. PD-1 expression by canine T cells and functional effects of PD-1 blockade.
Coy J; Caldwell A; Chow L; Guth A; Dow S
Vet Comp Oncol; 2017 Dec; 15(4):1487-1502. PubMed ID: 28120417
[TBL] [Abstract][Full Text] [Related]
57. Programmed death ligand-1 induction restrains the cytotoxic T lymphocyte response against microglia.
Chauhan P; Hu S; Prasad S; Sheng WS; Lokensgard JR
Glia; 2021 Apr; 69(4):858-871. PubMed ID: 33128485
[TBL] [Abstract][Full Text] [Related]
58. PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins.
Tai H; Yang Q; Wu Z; Sun S; Cao R; Xi Y; Zhao R; Zhang M; Zhang Z; Xu C
J Immunol Res; 2018; 2018():9485285. PubMed ID: 29854854
[TBL] [Abstract][Full Text] [Related]
59. High macrophage PD-L1 expression not responsible for T cell suppression.
Goldman N; Lomakova YD; Londregan J; Bucknum A; DePierri K; Somerville J; Riggs JE
Cell Immunol; 2018 Feb; 324():50-58. PubMed ID: 29305065
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma.
Yokoyama S; Miyoshi H; Nakashima K; Shimono J; Hashiguchi T; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Clin Cancer Res; 2016 Sep; 22(18):4727-34. PubMed ID: 27166394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
